The present study screened several DEGs in three datasets to reveal that increased levels of HELLS mRNA were significantly associated with poor OS in lung cancer patients, suggesting that HELLS may be a potential novel predictor of prognosis. This evidence concerns the gene HELLS and lung carcinoma.